Moreover, as most retrospective studies for macroscopic prostate cancer recurrence have used conventional imaging or predominantly choline PET/CT imaging as a pre-SRT staging method, data from PSMA PET/CT-based SRT for macroscopic relapse are still limited at present [10,11,12,13,14,15,16,17]. The gene discussed is FOLH1; the disease is prostate carcinoma.